Stay updated on Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    New help and navigation items were added to the page (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) along with a Revision: v3.6.0 tag, and the previous Intervention / Treatment heading and Revision: v3.5.5 tag were removed.
    Difference
    0.5%
    Check dated 2026-06-12T16:04:37.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.5, indicating a new release of the page content without altering the study details.
    Difference
    0.0%
    Check dated 2026-06-05T11:23:52.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a small update to the page metadata. This reflects an editorial change to the ClinicalTrials.gov record rather than any substantive study information.
    Difference
    0.0%
    Check dated 2026-05-15T04:21:01.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page now displays a new revision label: Revision: v3.5.3, replacing v3.5.2. This signals an update to the page version, with no evident public content changes.
    Difference
    0.0%
    Check dated 2026-04-30T18:50:35.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T11:16:47.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page. The change does not modify study data or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-03-18T19:22:03.000Z thumbnail image

Stay in the know with updates to Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page.